Analytics for Pharma and Biotech Traders
This is a list of Phase 3 trials with primary completion dates in February 2016 for companies with a market cap less than $1B. For complete clinical trial coverage, please see our Trial Tracker...
This is a list of Phase 3 trials with primary completion dates in January 2016 for companies with a market cap less than $1B. For complete clinical trial coverage, please see our Trial Tracker...
This is a list of Phase 3 trials with primary completion dates in December 2015 for companies with a market cap less than $1B. For complete clinical trial coverage, please see our Trial Tracker...
This is a list of Phase 3 trials with primary completion dates in November 2015 for companies with a market cap less than $1B. For complete clinical trial coverage, please see our Trial Tracker...
I’ve released a new tool, an Enhanced FDA Calendar. It shows all PDUFA dates, clinical trial primary completion dates, and working capital runways for companies facing upcoming PDUFA dates in a single, convenient timeline....
This is a list of Phase 3 trials with primary completion dates in October 2015 for companies with a market cap less than $1B. For complete clinical trial coverage, please see our Trial Tracker...
FDA Tracker’s site layout has always been responsive, but the products themselves previously required a minimum horizontal screen resolution to display all of the information. I’ve upgraded all of the tools to be responsive...
A minor update this month: the Adcom Explorer database now includes committees through June 4, 2015.
Trial Tracker, Burn Rate, and the FDA Calendar are useful tools for screening the universe of healthcare stocks for investment ideas. However, their data are segregated and they lack the ability to search for an individual...
Compiling PDUFA dates is hard. They must be gathered from a variety of sources because no central authority exists. Thus far, I’ve populated my FDA Calendar using a program I wrote to parse SEC filings for...